Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Thrombosis × Paclitaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 12 Carcinoma, Non-Small-Cell Lung 5 Ovarian Neoplasms 4 Uterine Cervical Neoplasms 3 Stomach Neoplasms 3 Neoplasms 3 Lung Neoplasms 3 Triple Negative Breast Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Thrombosis 1 Stage IA Uterine Sarcoma 1 Solid Tumors 1 Solid Tumor Cancer 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Peripheral Nervous System Diseases 1 Pancreatic Intraductal Neoplasms 1 Pancreatic Cyst 1 Pain 1 Organoid 1 Neoplasms, Germ Cell and Embryonal 1 NSCLC 1 Medulloblastoma 1 Malignant Airway Obstruction Secondary to Non-small Cell Lung Cancer 1 Infections 1 Hepatoblastoma 1

Interventions

fluorescein isothiocyanate-keyhole limpet hemocyanin 1 edoxaban 1 apixaban 1 X-Rays 1 Warfarin 1 Technetium Tc 99m Sulfur Colloid 1 Saline Solution 1 Rivaroxaban 1 Physical Therapy Modalities 1 Photons 1 Paclitaxel 1 Musculoskeletal Manipulations 1 Fondaparinux 1 Enoxaparin 1 Docetaxel 1 Dexmedetomidine 1 Dalteparin 1 Dabigatran 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04324346 2021-03-18

PICC&PAC

Swedish Red Cross University College

Phase NA Completed

Infections, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡